期刊文献+

高胆固醇血症患者血小板膜表达CD40配体 被引量:4

下载PDF
导出
摘要 研究高胆固醇血症患者血小板膜表达CD4 0配体 ,以探讨高胆固醇血症促动脉粥样硬化、血栓形成的机制。选择 2 5例高胆固醇血症患者及 2 5例年龄性别相匹配的健康对照者 ,采用流式细胞术测定血小板膜CD4 0配体和P选择素的表达 ,用酶联免疫吸附法测定血浆单核细胞趋化蛋白 1水平。结果发现 ,高胆固醇血症患者血小板膜CD4 0配体和P选择素的表达及血浆单核细胞趋化蛋白 1水平明显高于对照组 (P <0 .0 1) ,CD4 0配体表达与总胆固醇 (r=0 .4 1,P =0 .0 2 )及低密度脂蛋白胆固醇 (r=0 .5 6 ,P =0 .0 1)呈正相关 ,P选择素的表达与低密度脂蛋白胆固醇也呈正相关 (r=0 .79,P =0 .0 1)。结果提示 ,高胆固醇血症患者血小板膜表达CD4 0配体增加 ,高胆固醇血症可能是通过激活CD4 0配体而促进炎症反应、血栓形成 ,加速动脉粥样硬化的发生发展。
出处 《中国动脉硬化杂志》 CAS CSCD 2004年第2期223-224,共2页 Chinese Journal of Arteriosclerosis
  • 相关文献

参考文献7

  • 1Ross R.Atherosclerosis-an inflammatory disease.N Engl J Med,1999,340:115-126
  • 2Henn V,Slupsky JR,Grafe M,Anagnostopoulos I,Forster R,Muller-Berghaus G,et al.CD40 ligand on activated platelets triggers an inflammatory teaction of endothelial cells.Nature,1998,391:591-594
  • 3Grewal IS,Flavell RA.CD40 ligand.Immunol Res,1997,16:59-70
  • 4Phipps RP.Atherosclerosis:the emerging role of inflammation and the CD40-CD40 ligand system.Proc Natl Acad Sci USA,2000,97:6 930-932
  • 5李江,赵水平,彭道泉,李全忠,聂赛.西立伐他汀对THP-1细胞CD40和基质金属蛋白酶9表达的影响[J].中国动脉硬化杂志,2003,11(6):533-536. 被引量:8
  • 6Andre P,Prasad KS,Denis CV,He M,Papalia JM,Hynes RO,et al.CDL stabilizes arterial thrombi by a β 3 integrin-dependent mechanism.Nat Med,2002,8:247-252
  • 7Inwald DP,McDowall A,Peters MJ,Callard RE,Klein NJ.CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation.Cir Res,2003,92:1 041-048

二级参考文献18

  • 1[1]Ross R. Atherosclerosis-An inflammatory disease. N Eng J Med, 1999, 340 (2): 115-126
  • 2[2]Laman JD, De Smet BJ, Schoneveld A, Van Meurs M. CD40-CD40L interactions in atherosclerosis. Immunol Today, 1997, 18 (6): 272-277
  • 3[3]Mach F, Schonbeck U, Sukhova GK, Bourcier T, Bonnefoy JY, Pober JS, et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implication for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci USA, 1997, 94 (5): 1 931-936
  • 4[4]Rosenson RS,Tangney CC. Antiatherothrombotic properties of statins: implication for cardiovascular event reduction. JAMA, 1998, 279 (20): 1 643-650
  • 5[5]Vaughan CJ, Murphy MB, Buckley BM. Statins do more than just lower cholesterol. Lancet, 1996, 348 (9034): 1 079-082
  • 6[6]Sparrow CP, Burton CA, Hernandez M, Mundt S, Hassing H, Patel S, et al. Simvastatin has anti-inflammatory and antiatheosclerotic activties independent of plasma cholesterol lowering. Arteroscler Thromb Vasc Biol, 2001, 21 (1): 115-121
  • 7[7]LutgensE, Cleutjens KB, Heeneman S, Koteliansky VE, Burkly LC, Daemen MJ, et al. Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype. Proc Natl Acad Sci USA, 2000, 97 (13): 7 464-469
  • 8[8]Peter Libby. Current concept of the pathogensis of the acute coronary syndrome. Circulation, 2001, 104 (3): 365-372
  • 9[9]Brown DL, Hibbs MS, Kearney M, Loushin C, Isner JM. Identification of 92-kDa gelatinase in human coronary atherosclerotic lesions:association of active enzyme synthesis with unstable angina. Circulation, 1995, 91(8): 2 125-131
  • 10[10]Henney AM, Wakeley PR, Davies MJ, Foster K, Hembry R, Murphy G, et al. Localization of stromelysin gene expression in atherosclerotic plaque by an in situ hybridization. Proc Natl Acad Sci USA, 1991, 88 (18): 15J-20J

共引文献7

同被引文献32

  • 1余舒杰,陈璘.血清淀粉样蛋白A与冠心病的一级预防[J].循证医学,2004,4(4):231-235. 被引量:1
  • 2陈赞,凌锋.动脉粥样硬化相关基因的研究进展[J].中国脑血管病杂志,2005,2(1):39-42. 被引量:3
  • 3张建丽,叶德平.高血压病血脂异常与中医辨证分型关系探讨[J].河北中医,2005,27(4):264-265. 被引量:18
  • 4陈凤花,王琳,胡丽华.实时荧光定量RT-PCR内参基因的选择[J].临床检验杂志,2005,23(5):393-395. 被引量:58
  • 5Ross R. Atherosclerosis-an inflammstory disease[J]. N Engl J Med, 1999,340:115.
  • 6Lutgens E, Daemen MJ. CD40-CD40L interactions in atheroeclerosis[ J]. Trends Cardeovasc Med ,2002 ,12 :27.
  • 7Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non- ST-segment elevation myocardial infartion[J]. J Am Coll Cardiol, 2000,36:970.
  • 8Mach F,Schonbeck U,Libby P. CD40 signaling in vascular cells:A key role in athero-sclerosis [ J ]. Atheroscleroels, 1998,137 : 89.
  • 9Kumanogoh A,Wang X,Lee I,et al. Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: a role of CD40 in regulatory T cell development[J]. J Immunol,2001,166:353.
  • 10Heeschen C, Dimmelor S,Hamm CW,et al. Soluble CD40 ligand in acute coronary syndromes[ J]. The New England Journal of Medicine,2003,348(12) :1104.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部